Accelerate Diagnostics (AXDX) Misses Q4 EPS by 9c

Accelerate Diagnostics (NASDAQ: AXDX) reported Q4 EPS of ($0.34), $0.09 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $3.7 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15